PT759995E - Glicoproteina de fusao a partir de hcmv e esv - Google Patents

Glicoproteina de fusao a partir de hcmv e esv

Info

Publication number
PT759995E
PT759995E PT95919447T PT95919447T PT759995E PT 759995 E PT759995 E PT 759995E PT 95919447 T PT95919447 T PT 95919447T PT 95919447 T PT95919447 T PT 95919447T PT 759995 E PT759995 E PT 759995E
Authority
PT
Portugal
Prior art keywords
glycoprotein
hcmv
fusao
esv
hsv
Prior art date
Application number
PT95919447T
Other languages
English (en)
Inventor
Dirk R Gheysen
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of PT759995E publication Critical patent/PT759995E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01DNA viruses
    • C07K14/03Herpetoviridae, e.g. pseudorabies virus
    • C07K14/035Herpes simplex virus I or II
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT95919447T 1994-05-18 1995-05-11 Glicoproteina de fusao a partir de hcmv e esv PT759995E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9409962A GB9409962D0 (en) 1994-05-18 1994-05-18 Novel compounds

Publications (1)

Publication Number Publication Date
PT759995E true PT759995E (pt) 2005-07-29

Family

ID=10755348

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95919447T PT759995E (pt) 1994-05-18 1995-05-11 Glicoproteina de fusao a partir de hcmv e esv

Country Status (21)

Country Link
US (3) US5889168A (pt)
EP (2) EP1529845B1 (pt)
JP (1) JPH10500009A (pt)
KR (1) KR970703428A (pt)
AT (2) ATE483809T1 (pt)
AU (1) AU2527195A (pt)
BR (1) BR9507728A (pt)
CA (1) CA2190529A1 (pt)
CY (1) CY2597B2 (pt)
DE (2) DE69536112D1 (pt)
DK (1) DK0759995T3 (pt)
ES (2) ES2239758T3 (pt)
GB (1) GB9409962D0 (pt)
HK (1) HK1012415A1 (pt)
HU (1) HU9603163D0 (pt)
NO (1) NO964874L (pt)
PL (1) PL317235A1 (pt)
PT (1) PT759995E (pt)
SI (1) SI0759995T1 (pt)
WO (1) WO1995031555A1 (pt)
ZA (1) ZA953961B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409962D0 (en) * 1994-05-18 1994-07-06 Smithkline Beecham Biolog Novel compounds
KR20010041629A (ko) * 1998-03-09 2001-05-25 장 스테판느 혼합 백신 조성물
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
AU2005299923A1 (en) * 2004-10-22 2006-05-04 Cargill, Incorporated Process for the production of maltodextrins and maltodextrins
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
KR101652060B1 (ko) * 2008-12-25 2016-08-29 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 재조합 닭 전염성 코라이자 백신 및 그 제조방법
CA2779459A1 (en) 2009-10-30 2011-05-05 The Administrators Of The Tulane Educational Fund Peptide compositions and methods for inhibiting herpesvirus infection
TW201305190A (zh) 2010-10-15 2013-02-01 Glaxosmithkline Biolog Sa 新穎之抗原
EP3888675A1 (en) * 2013-09-24 2021-10-06 Duke University Compositions, methods and kits for eliciting an immune response
US10611800B2 (en) 2016-03-11 2020-04-07 Pfizer Inc. Human cytomegalovirus gB polypeptide
US11629172B2 (en) 2018-12-21 2023-04-18 Pfizer Inc. Human cytomegalovirus gB polypeptide
TWI810589B (zh) 2020-06-21 2023-08-01 美商輝瑞股份有限公司 人巨細胞病毒糖蛋白B(gB)多肽

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
EP0289550B1 (en) * 1986-10-20 1996-04-10 Chiron Corporation Vaccine for use in the therapeutic treatment of hsv
WO1989007143A1 (en) * 1988-01-29 1989-08-10 Chiron Corporation Recombinant cmv neutralizing proteins
GB9409962D0 (en) * 1994-05-18 1994-07-06 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
BR9507728A (pt) 1997-09-23
DK0759995T3 (da) 2005-08-01
US6036959A (en) 2000-03-14
EP1529845B1 (en) 2010-10-06
ATE483809T1 (de) 2010-10-15
WO1995031555A1 (en) 1995-11-23
CA2190529A1 (en) 1995-11-23
KR970703428A (ko) 1997-07-03
EP0759995A1 (en) 1997-03-05
ES2353134T3 (es) 2011-02-25
PL317235A1 (en) 1997-03-17
HK1012415A1 (en) 1999-07-30
NO964874D0 (no) 1996-11-15
EP1529845A3 (en) 2006-03-08
SI0759995T1 (en) 2005-10-31
ATE293697T1 (de) 2005-05-15
US5889168A (en) 1999-03-30
DE69534162T2 (de) 2006-03-09
DE69536112D1 (de) 2010-11-18
NO964874L (no) 1996-11-15
DE69534162D1 (de) 2005-05-25
EP0759995B1 (en) 2005-04-20
HU9603163D0 (en) 1997-01-28
JPH10500009A (ja) 1998-01-06
EP1529845A2 (en) 2005-05-11
GB9409962D0 (en) 1994-07-06
AU2527195A (en) 1995-12-05
ES2239758T3 (es) 2005-10-01
ZA953961B (en) 1996-02-26
US5739292A (en) 1998-04-14
CY2597B2 (en) 2010-03-03

Similar Documents

Publication Publication Date Title
CY2597B2 (en) Fusion glycoprotein from HCMV and HSV
KR100386762B1 (ko) 재조합사람혈청알부민의제조방법
DE69434520D1 (de) Biotinylierung von proteinen
DE69739673D1 (de) Affinitätsreinigung von Polypeptid-Proteinen auf einer Protein A Matrix
DE69624591D1 (de) Leitweglenkung von paketen
DE69514830D1 (de) Coproduktion von kaliumsulfat und natriumsulfat
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
ATE113597T1 (de) Antagonisten von excitatorischen aminosäuren.
KR950702242A (ko) 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins)
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
ATE78041T1 (de) Beschirmendes peptidantigen uebereinstimmend mit plasmodium-falciparum-circumsporozoitprotein.
FR2733858B1 (fr) Convertisseur de lumiere d'infrarouge lointain au proche infrarouge
DE69738967D1 (de) Stabile expression von tripelhelikalen proteinen
DE69717677D1 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE59607328D1 (de) Verwendung von modifizierten polyasparaginsäuren in waschmitteln
FI953422A (fi) Autolysoivia fuusioproteiineja hyväksikäyttävät ilmentämisjärjestelmät ja uusi pelkistävä polypeptidi
DE69329347D1 (de) Immunreaktive peptide des epstein-barrvirus
FI944997A0 (fi) Parannettu rekombinantti-proteiinien tuotanto
DE59611517D1 (de) Verwendung von feinstteiligen Thermoplasten
DE69331549D1 (de) Nachweiss von anti-hpa antikörpern
NO992531D0 (no) FremgangsmÕter ved fremstilling av rekombinant protein
DE59810255D1 (de) Nachweis von Knorpelerkrankungen mit MIA
DE59006998D1 (de) Verfahren zur herstellung von hirudin.
DK0765019T3 (da) En flyveplads' serieforbundne forsænkede lys
BR9301832A (pt) Processo de desidratação de sangue animal e farinha de sangue obtida